-
Fight CRC webinar Dr. Axel Grothey with a recap of some of the research presented at the
#GI20 for#colorectalcancer Here's a link to a time stamp outline of the topics: REGONIVO, BEACON, CHECKMATE 142, Liquid Biopsies & COBRA trial, IPACS study@agrothey https://www.facebook.com/stage4crcsupport/posts/1571161556369719?__tn__=-R … -
Danielle S. Bitterman, MD, on Pancreatic Cancer: Noninvasive Genomic Profiling From Plasma ctDNA http://ascopost.com/videos/2020-ga …
#pancsm#GI20#oncology#cancer#genomics@dbittermanmd@DanaFarber@MGHCancerCenter pic.twitter.com/7TEMoszbiZ
-
"A small study of 48 patients with locally advanced rectal cancer receiving neoadjuvant chemotherapy, found that patients receiving lower-than-recommended doses in fact saw their tumors shrink more than patients receiving the full dose." https://www.newswise.com/articles/less-chemotherapy-may-have-more-benefit-in-rectal-cancer …
@FightCRC#GI20 -
Should the recommended colonoscopy screening age be lowered? Uri Ladabaum, MD of
@StanfordMed and David Weinberg, MD of@FoxChaseCancer debated on the matter during the#GI20 and also discussed the debate during an interview with Targeted Oncology. https://www.targetedonc.com/news/doctors-debate-should-the-screening-age-for-colonoscopy-be-reduced-in-averagerisk-patients …#CRCsm -
Scott Kopetz, MD, PhD, on Metastatic Colorectal Cancer: Quality of Life Results on Encorafenib, Cetuximab, and Binimetinib http://ascopost.com/videos/2020-ga …
#CRCSM#oncology#cancer#GI20@MDAndersonNewspic.twitter.com/AoKAWTgbHF
-
No sound is sweeter to my ears than personalized supportive cancer care. Precision cancer care delivery (a la
@yzafar stellar keynote at#GI20) is just as critical as NGS in provider truly comprehensive cancer care. Can't wait!#GIonc#pallonc#supponchttps://twitter.com/hannahrwardill/status/1225087440215474178 … -
Brian M. Wolpin, MD, on Performance of a Blood-Based Test for the Detection of Multiple
#Cancers http://ascopost.com/videos/2020-ga …#oncology#GI20@DanaFarber @HaleCenter_DFCIpic.twitter.com/ZokqvQ2Stg
-
Atualização dos dados do BEACON trial na ASCO GI mantendo ganho de SG e com qualidade de vida! Doublet como standard no tratamento p/pts CCRm BRAFm V600E pós falha a 1a linha. Pena que custo ainda exorbitante + vale mais uma vez a discussão de valor na oncologia!
#GI20 pic.twitter.com/LXtru331x3
-
In the cohort of patients that received lenvatinib in the frontline setting, the ORR was 14.0% versus 4.0% in those that received therapy in the second- to fourth-line settings. https://www.targetedonc.com/news/lenvatinib-appears-effective-in-reallife-retrospective-analysis-of-advanced-hcc …
#GI20#hcc -
On
#WorldCancerDay
, we recognize pharmacists who are advancing the treatment of cancer. Assistant Professor Ashley Glode, PharmD, recently presented a poster at the #GI20 showing that less chemotherapy may have more benefit in rectal cancer.#TuesdayTrends http://bit.ly/2SarjJ4 -
Here we are ! Updates from
#gi20 are now ready! Videos released and downloadable slides available on our website. Please enjoy reading and watching!!#oncology#MedEdhttps://giconnect.info/update-from-asco-gi-2020/ … -
Dr. Lenz “The incredible complete response rates & overall response rates seen are never seen with chemotherapy, & it’s very well tolerated, so if I have a choice, I would start with nivolumab-ipilimumab in 1st-line
#MSI -H...”#CRCSM from ASCO#GI20 https://www.mdedge.com/hematology-oncology/article/216373/gastroenterology/dual-immunotherapy-goes-distance-msi-h … -
This combination resulted in an overall response rate of 81% in patients with RAS/BRAF-wildtype metastatic colorectal cancer. https://www.targetedonc.com/conference/ascogi-2020/avelumab-added-to-standard-regimen-for-crc-achieves-high-response-rate-but-misses-pfs-end-point …
#coloncancer#Gi20 -
I was told by an expert at ASCO
#GI20 that lung mets also respond better to immunotherapy than liver mets. -
Eyal Meiri, MD, on Pembrolizumab in Colorectal Cancer: Results From the TAPUR Study https://www.ascopost.com/videos/2020-gastrointestinal-cancers-symposium/eyal-meiri-on-pembrolizumab-in-colorectal-cancer/ …
#crcsm#oncology#cancer#GI20 pic.twitter.com/Y8iWk6GYdL
-
"Meetings like
#GI20 serve as an important reminder of the brilliant and compassionate people around the world who are working every day to improve outcomes for patients facing GI cancers, like#pancreaticcancer."@LynnMatrisian@PanCANhttps://twitter.com/PanCAN/status/1223009245580472322 … -
Immunotherapy Combo Improves Quality of Life for People With Liver Cancer
@LizCancerHealth https://www.hepmag.com/article/immunotherapy-combo-improves-quality-life-people-liver-cancer …#livercancer#GI20 -
"Hit the wall" last night... with some patient advocacy burnout. LOVED going to ASCO
#GI20... but need to get the damn dishes washed! My motto today: try to do the least I can do. Feel better already! -
There may be a gut microbe connection to the increased incidence of CRC in younger patients.
#GI20 http://ms.spr.ly/6011TZMXZ
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.